LAS VEGAS, NV--(Marketwired - Aug 18, 2016) - DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), an independent cannabis testing lab and media firm, is pleased to announce it has been selected as the laboratory testing service provider for The Clinic Nevada, LLC, a licensed cannabis cultivator, producer, and dispenser located in Las Vegas, Nevada. The Clinic has numerous retail and cultivation locations in Colorado and Illinois. The Clinic Nevada is excited to launch sub-brands, The Lab concentrates and The Bank flowers in Nevada which will be sold both in the wholesale market and through their storefront, at 4310 W. Flamingo Rd.
Currently, DigiPath tests products coming out of The Clinic Nevada's production facility branded as "The Lab".
Jon Marshall, COO of The Clinic Nevada, said, "We are thrilled to be working with DigiPath Labs here in Las Vegas. In the few months we've been operational, DigiPath has gone above and beyond what we expected from a lab. From quick turnarounds on test results to consulting services to their fantastic passionate team, we've been very pleased with everything DigiPath has to offer. We wanted to carry over our success from Colorado and we knew partnering with a quality lab like DigiPath would be the way to help us do that."
DigiPath Labs' state-of-the-art Las Vegas laboratory was developed to elevate the standard for cannabis testing. The team carefully selected equipment and verified standard operating procedures to ensure reliable, replicable results. DigiPath is honored to have been chosen as the laboratory-testing provider for such a well-renowned brand.
Todd Denkin, President of DigiPath, commented, "Jon Marshall and the crew over at The Clinic have been wonderful to work with. They are committed to growing and producing clean and safe cannabis products. We are excited that they have chosen DigiPath Labs to ensure the safety and quality of their brand."
To learn more about DigiPath Labs, visit www.digipathlabs.com.
About DigiPath, Inc.
DigiPath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry's best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. DigiPath's two business units are DigiPath Labs and TNM News Corp. DigiPath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis.
For more information please visit http://www.digipath.com/.
About The Clinic, Nevada
The Clinic Nevada is excited to replicate our proven success and track record in Colorado by opening a flagship dispensary here in Las Vegas, Nevada. The Clinic was founded with a focus on patient education, community support, and commitment to the industry, and premium, consistent products. We are proud to bring the knowledge, techniques, and dedication to quality that our growers, processors, extractors and bud tenders are known for to Nevada. The Clinic has been recognized as an industry leader for nearly a decade and we have been fortunate enough to have been awarded dozens of industry awards in a broad range of categories, ranging from flowers and genetics, to concentrates, to business and political leadership, to philanthropic and volunteer activities. With a staff nearing 150 in 3 states, including Colorado, Illinois, and now Nevada, the Clinic is looking forward to cultivating happiness wherever we go.
For more information please visit http://www.theclinicnevada.com/.
This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, governmental regulation of the cannabis industry, the demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.